Accelerated partial breast irradiation via the mammosite® catheter: Preliminary reports of a single-institution experience

Breast Journal

Volumn 15, Issue 6, 2009, Pages 603-609

  Guenzi, Marina ^a   Giannelli, Flavio ^a   Azinwi, Che ^b   Ricchetti, Francesco ^b   Vagge, Stefano ^b   Canavese, Giuseppe ^a   Massa, Tiberio ^a   Garelli, Stefania ^a   Carli, Franca ^a   Corvò, Renzo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Brachytherapy; Breast cancer; Mammosite; Partial breast irradiation; Toxicity

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; BREAST CANCER; CANCER RADIOTHERAPY; CATHETER; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ESTHETIC SURGERY; HUMAN; OUTCOME ASSESSMENT; PARTIAL BREAST IRRADIATION; PARTIAL MASTECTOMY; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; SEROMA; SKIN TOXICITY; TUMOR VOLUME; X RAY;

AGED; BRACHYTHERAPY; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70449646878     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2009.00836.x     Document Type: Article

References (33)

1. Fisher b, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-1241
2. 2. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 2001;12:997-1003. (Pubitemid 32725776)
3. Fyles A, McCready D, Manchul L, et al. Tamoxifen with or without irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 2004;351:1021-1023
4. Uppsala-Orebro Breast Cancer Study Group. Sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomised trial. J Natl Cancer Inst 1990;82: 277-282
5. 5. Holland R, Velig SH, Mravunac M, et al. Histologic multifocality of Tis, T1-2 breast carcinoma. Implications for clinical trial of breast consrving surgery. Cancer 1985;56:979. (Pubitemid 15003474)
6. Clark R, McCulloch P, Levine M, et al. Randomised clinical trialto asses the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 1992;84:683-689
7. 7. Liljegren G, Holmberg L, Bergh J, et al. 10-Years results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomised trial. J Clin Oncol 1999;17:2326-2333 (Pubitemid 29368230)
8. 8. Smith TE, Lee D, Turner BC, et al. True recurrence versus new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic difference and their implications in natural history, prognoses, and therapeutic management. Int J Radiât Oncol Biol Phys 2000;48:1281-1289 (Pubitemid 30838354)
9. 9. Huang E, Buchholz TA, Meric F, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumor have more favourable outcome than true local disease recurrences. Cancer 2002;95:2059-2067 (Pubitemid 35253366)
10. 10. Arthur DW, Vicini FA. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol 2005;23:1726-1735 (Pubitemid 46211425)
11. Swanson TA, Vicini FA. Overview of accelerated partial breast irradiation. Curr Oncol Rep 2008;10:54-60.
12. Harper JL, Jenrette JM, Vanek KN, et al. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience. Int J Radiat Oncol Biol Phys 2005;61:169-174
13. 13. Vicini F, Beitsch PD, Quiet CA, Keleher AJ, et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer 2008;112:758-766 (Pubitemid 351240569)
14. 14. Niehoff P, Ballardini B, Polgár C. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer. Breast 2006;15:319-325 (Pubitemid 43840880)
15. 15. Polgar C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma - 5-year results of a randomized trial. Int J Radiat Oncol Biol Phys 2007;69:694-702 (Epub May 25, 2007). (Pubitemid 47418409)
16. 16. Niehoff P, Polgár C, Ostertag H, Major T, et al. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial. Radiother Oncol. 2006;79:316-20 (Epub Jun 14, 2006). (Pubitemid 44109912)
17. 17. Cefaro GA. Predictors of local recurrence after conservative surgery and whole-breast irradiation. Breast Cancer Res Treat 2006;98:329-335 (Pubitemid 44195603)
18. 18. Leong C, et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer 2004;100:1823-1832 (Pubitemid 38529559)
19. 19. Bartelink H, Horior JC, Poortman PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007;25:3259-3265 (Pubitemid 47325610)
20. RTOG Acute Radiation Morbidity Scoring Criteria, Radiation Therapy Oncology Group. Available at: http://www.rtog.org/ members/toxicity/acute.html
21. LENT/SOMA Tables. Radiother Oncol 1995; 35:17-60.
22. 22. Rose MA, Olivotto I, Cady B, et al. Conservative surgery and radiation therapy for early breast cancer. Long term cosmetic results. Arch Surg 1989;124:153-157 (Pubitemid 19059735)
23. Jacobson JA, Danforth DN, Cowan KH. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995;332:907-911,
24. 24. Fisher B, Anderson S, Bryant J. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-1241 (Pubitemid 35176242)
25. 25. Veronesi U, Paganelli G, Viale G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 2006;7:983-990 (Pubitemid 44804136)
26. 26. Shen J, Gilcrease MZ, Babiera GV. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 2007;109:1255-1263 (Pubitemid 46466551)
27. Prosnitz LR, Marks LB. Partial breat irradiation: a cautionary note. Int J Radiat Oncol Biol Phys, 2006;65:319-321
28. 28. Chen S, Dicker A, Kirk M, et al. Patterns of failure after mammosite brachytherapy partial breast irradiation: a detailed analysis. Int J Radiat Oncol Biol Phys 2007;69:25-31, (Pubitemid 47247513)
29. Zannis V, Beitsch P, Vicini F, et al. Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Am J Surg 2005;190:530-538
30. 30. Benitez PR, Keisch ME, Vicini F, et al. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 2007;194:456-462 (Pubitemid 47370993)
31. Prestidge B, Sadeghi A, et al. Local control of early stage breast cancer using MammoSite HDR brachitherapy. Int J Radiat Oncol Biol Phys 2006;66:S215.
32. 32. Chao K, Vicini F, et al. Analysis of treatment efficacy, cosmesis and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial breast irradiation: the Willian Beaumont Hospital experience. Int J Radiat Biol Oncol Phys 2007;69:32-40. (Pubitemid 47247500)
33. Dragun AE, Harper JL, et al. Predictors of cosmetic outcome following MammoSite Breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys 2007;68:354-358